Personalizing therapy for inflammatory bowel diseases.

about

Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Improving IBD Care: A Personalized Approach to Management.

P2860

Q38177338-8F078FC0-3544-4C5F-A0B0-77A0CC12F688 Q38735146-29D43B08-25F5-4A2E-A317-CF44822B8E94 Q55512056-EC409FA7-7001-4944-A5CD-8BDB576BE1D7

P2860

Personalizing therapy for inflammatory bowel diseases.

Item

http://www.wikidata.org/entity/Q38132279

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Personalizing therapy for inflammatory bowel diseases.

@en

type

Item

label

Personalizing therapy for inflammatory bowel diseases.

@en

prefLabel

Personalizing therapy for inflammatory bowel diseases.

@en

P1476

Personalizing therapy for inflammatory bowel diseases.

@en

P2093

Ashwin N Ananthakrishnan

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice

Genetic predictors of medically refractory ulcerative colitis

Inflammatory bowel disease

Genetics and pathogenesis of inflammatory bowel disease

Epidemiology and natural history of inflammatory bowel diseases

Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis.

P304

549-558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2013.824693

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23985004

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

Personalizing therapy for inflammatory bowel diseases.

about

P2860

P2860

Personalizing therapy for inflammatory bowel diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921